Boston Scientific Matches Profit Expectations, But Provides Downbeat Outlook

Medical products and technology company Boston Scientific Corp. reported on Tuesday a first-quarter loss of $1 million, or breakeven on a per-share basis, compared with a profit of $133 million, or 10 cents a share, in the year-earlier period.